On International Women's Day (IWD), Emerge Australia ambassador Tracey Spicer AM gives chronically ill women a voice. Read more
Calls for greater government support for patients living with invisible illnesses like ME/CFS and Long COVID Read more
The Pharmaceutical Benefits Advisory Committee recommended changes to the Pharmaceutical Benefits Scheme (PBS) eligibility criteria of oral treatments for COVID-19. Read more
Health authorities around the world are spending billions on tackling Long COVID, with innovative research projects for new treatments and comprehensive patient support. In Australia, things are a little different. The ABC's Sophie Scott and Stephanie Dalzell recently spoke with Emerge Australia's CEO, Anne Wilson, as part of their story on the Federal Governments underfunding of Long COVID in Australia. Read more
We know how difficult it is to find a GP with knowledge of ME/CFS. One of the main aims for our GP education program is to grow the GP workforce confident to take on people with complex presentations. Read more
Our International Roundup provides a brief snapshot of some of the ME/CFS research funding, clinical care and advocacy actions around the world in the last few months. Read more
Anne Wilson, Emerge Australia's CEO, has expressed disappointment as the budget provided no funding for sufferers of Long COVID or other post-viral conditions. Read more
Media Release 12 October 2022 - Members of Parliament across Australia are set to come face to face with the harsh reality of the impact and destruction of the lives of tens of thousands of Australians facing the daily battle of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), for which there is no known cure. Read more
Emerge Australia presented the keynote address on Sunday 23 July, at the second GPCE conference for 2022 in Perth. Just as at Sydney’s conference, Emerge Australia’s Medical Director Dr Richard Schloeffel, OAM, presented about diagnosis, management and treatment options for Long COVID and ME/CFS. Read more